ENDRA Life Sciences Analyst Ratings
Buy Rating Upheld for ENDRA Life Sciences on Strong Medical Imaging Progress and Market Potential
Analysts Are Bullish on These Healthcare Stocks: Anavex Life Sciences (AVXL), ENDRA Life Sciences (NDRA)
H.C. Wainwright Sticks to Their Buy Rating for ENDRA Life Sciences (NDRA)
Analysts Offer Insights on Healthcare Companies: GT Biopharma (GTBP), Eton Pharmaceuticals (ETON) and ENDRA Life Sciences (NDRA)
No Data
No Data